Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

We're still translating this one. In a couple of days, you'll see what this trial actually tests, and whether it matters for APOE4 carriers like you. For now, here's the sponsor's own description:

PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the benefit of statins for reducing the primary composite of death, dementia, and persistent disability and secondary composites including mild cognitive impairment (MCI) and cardiovascular events.